About me
Dr. Huan Wang joined the FDA in 2021, where he focuses on statistical reviews for drug approval applications in non-malignant hematologic diseases. Prior to this role, he earned his Ph.D. in Biostatistics from the George Washington University, where he conducted research on developing machine learning-based prognostic systems for cancer patients. His current projects involve developing effect sizes for survival analysis, statistical modeling for externally controlled trials, and Bayesian borrowing in pediatric and rare disease studies.
